Andrew Lock

Andrew Lock currently serves as the Life Sciences Market Lead at Gene, a position held since April 2023. Prior to this role, Andrew was a Project Manager at Cayman Chemical from March 2022 to April 2023, focusing on product development, regulatory affairs consulting, and contract research for pharmaceuticals and medical devices. Andrew's experience also includes working as an Operations Manager at Thermo Fisher Scientific from February 2021 to March 2022, where responsibilities included supervising GMP manufacturing and leading continuous improvement projects. Additionally, Andrew worked as an Operations Coordinator at Tempus AI from May 2018 to January 2021, delivering personalized treatment plans for cancer patients. Andrew holds a degree from Michigan State University.